Clobazam
- Product NDC
- 66689-058
- 11-digit product format
- 666890058
- Labeler code
- 66689
- Product ID
- 66689-058_efca6cd2-125e-4593-9d45-d2fd3e763d92
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clobazam
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- VistaPharm, Inc.
- Application
- ANDA210746
- Marketing category
- ANDA
- Marketing start
- 2019-08-30
- Marketing end
- 0000-00-00
- Substance
- CLOBAZAM
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 66689-058 | CLOBAZAM SUSPENSION [VISTAPHARM, LLC] | 18 | Legacy NDC | 20240712_879e57c5-47ce-4942-acbb-6263951ba591.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 66689-058-04 | 66689005804 | 1 BOTTLE, PLASTIC in 1 CARTON (66689-058-04) > 120 mL in 1 BOTTLE, PLASTIC | 2019-08-30 | 0000-00-00 | No | No | Current |